Role Overview:
Legend Biotech is a clinical stage biopharmaceutical company focused on the discovery and development of novel cell therapies for oncology, immunology and infectious disease indications. We are currently seeking talented and motivated individuals to join the group of Cell Biology and Immunology in the R&D Department located at Piscataway of New Jersey. The successful candidate should possess extensive knowledge and hands-on experience in oncology, cell biology and immunology, in particular TCR-T/CAR-T cell biology. The candidate will be able to contribute to the effort for developing T cell therapy platform, building and optimizing cell-based immunoassays to characterize and assess TCR-T/CAR-T cell functions. Experience with TCR-T/CAR-T cells is preferred. As major contributors of pipeline development, the candidates need to demonstrate the ability of planning, designing, executing complicated experiments and delivering scientific results in a cross-functional environment. This position also requires supervision and management skills.
Major Responsibilities:
Education:
Experience:
Key Capabilities, Knowledge, and Skills:
Legend Biotech USA Inc. is a proud equal opportunity/affirmative action employer committed to attracting, retaining, and maximizing the performance of a diverse and inclusive workforce. It is Legend’s policy to ensure equal employment opportunity without discrimination or harassment based on race, color, religion, sex (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity or expression, age, disability, national origin, marital or domestic/civil partnership status, genetic information, citizenship status, uniformed service member or veteran status, or any other characteristic protected by law.
Legend Biotech USA Inc. maintains a drug-free workplace.
Job details are sourced from the employer's original posting.
Open job postingAbout the company
At Legend Biotech, we are excited to bring clinical trials to patients in our pursuit of a cure. While we are focusing on CAR-T in multiple myeloma, we firmly believe the prospects of cellular therapy stretch beyond just one disease or indication. The spark of hope is lit. At Legend Biotech, we are using that hope to ignite the future of CAR-T cell therapy.